Small Cap
Drug Manufacturers - General
Stocks Ranked by
Market Capitalization
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
|
AMRN
1
Amarin Corp
AMRN
$292M
| $292M | $13.94 | 1.69% |
|
2
Lineage Cell Therapeutics
LCTX
$289M
| $289M | $1.16 | 0.85% |
|
Small Cap Drug Manufacturers - General Stocks at a Glance
Large drug manufacturers sell diversified portfolios of branded medicines backed by deep development pipelines. Patent lives set the clock: blockbuster franchises fund the R&D and acquisitions needed to outrun expirations, supporting durable margins and dividends.
There are 2 small cap Drug Manufacturers - General stocks — companies in the Drug Manufacturers - General industry with a market cap between $250M and $2B — worth a combined $581M.
The largest by market cap are Amarin Corp (AMRN) at $292M and Lineage Cell Therapeutics (LCTX) at $289M.
Among institutional investors, Lineage Cell Therapeutics (LCTX) drew the most net new fund positions in Q1 2026: 24 funds opened new positions, taking total fund holders up 7 (5.7%) quarter-over-quarter.
- Combined market cap: $581M across 2 stocks.
- Small Cap: market cap between $250M and $2B.
- Largest constituent: Amarin Corp (AMRN), $292M market cap.
- Most net new fund positions in Q1 2026: Lineage Cell Therapeutics (LCTX), +7 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.